Search

Search Constraints

You searched for: Author/Creator Doubek, Michael

Search Results

1. A novel germline mutation in GP1BA gene N-terminal domain in monoallelic Bernard-Soulier syndrome. (17th November 2018)

2. A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. Issue 9 (3rd July 2016)

3. Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia. (24th January 2020)

4. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial. Issue 9980 (9th May 2015)

5. Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients. Issue 10 (29th July 2017)

6. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI. Issue 4 (13th February 2017)

7. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI. Issue 4 (13th February 2017)

8. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification. Issue 8 (16th March 2020)

9. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status. Issue 1 (2nd January 2017)

10. Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV. (21st September 2016)